MedTrace Logo

Maternal High Blood Pressure and Newborn's Blood Profile

NCT03265704 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6108

Last updated 2017-08-29

No results posted yet for this study

Summary

Maternal high blood pressure remodels the intrauterine environment of the fetus by altering hormonal and cellular signaling patterns and, as a result increases the risk of fetal and neonatal mortality and morbidity. Newborns of these mothers have an increased risk of intrauterine growth restriction, premature birth and hematological abnormalities, such as thrombocytopenia, polycythemia, and neutropenia. The purpose of the article is to review neonatal thrombocytopenia and neutropenia as a consequence of maternal high blood pressure and to establish the optimal management of these cases.

Conditions

  • Maternal-Fetal Exchange

Interventions

OTHER

AGA - Control group

Data processing from Patient Medical Files

OTHER

SGA - Control group

Data processing from Patient Medical Files

OTHER

AGA-PIH Study group

Monitoring PIH-related changes in the newborn

OTHER

SGA-PIH Study group

Monitoring PIH-related changes in the newborn

Sponsors & Collaborators

  • University of Medicine and Pharmacy "Victor Babes" Timisoara

    collaborator OTHER

  • Timişoara County Emergency Clinical Hospital

    collaborator OTHER

  • Romanian Society of Anesthesia and Intensive Care

    lead OTHER

Principal Investigators

  • Alexandru Florin Rogobete, PhDs · Romanian Society of Anesthesia and Intensive Care

  • Dorel Sandesc, Prof · Romanian Society of Anesthesia and Intensive Care

  • Ovidiu Bedreag, Assoc Prof · Romanian Society of Anesthesia and Intensive Care

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2017-08-25
Completion
2017-08-25

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03265704 on ClinicalTrials.gov